KZR
Kezar Life Sciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$53.86M
P/E Ratio
—
EPS
$-6.17
Beta
0.41
52W High
$7.55
52W Low
$0.16
50-Day MA
$7.13
200-Day MA
$5.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Kezar Life Sciences Inc
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of new small molecule therapies to address the unmet needs in immune-mediated diseases and cancer in the United States. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-33.76M |
| EBITDA | $-51.37M |
| Operating Margin | 0.00% |
| Return on Equity | -59.90% |
| Return on Assets | -29.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $9.56 |
| Price-to-Book | 0.77 |
| Price-to-Sales (TTM) | 6.03 |
| EV/Revenue | - |
| EV/EBITDA | 0.06 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.39M |
| Float | $5.16M |
| % Insiders | 15.78% |
| % Institutions | 61.26% |
Historical Volatility
HV 10-Day
8.52%
HV 20-Day
8.27%
HV 30-Day
53.96%
HV 60-Day
46.94%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($6.00 target)
3
HoldMore HEALTHCARE Stocks
Data last updated: 5/16/2026